GRAND PHARMA(00512),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

00512 GRAND PHARMA

Trading 03-10 11:25:26

7.390

+0.210

+2.92%

High7.420	Low7.180	Vol2.39M
Open7.180	D1 Closing7.180	Amplitude3.34%
Mkt Cap26.23B	Tradable Cap26.23B	Total Shares3.55B
T/O17.58M	T/O Rate0.07%	Tradable Shares3.55B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"00512","market":"HK","secType":"STK","nameCN":"GRAND PHARMA","latestPrice":7.39,"timestamp":1773113092813,"preClose":7.18,"halted":0,"volume":2388500,"delay":0,"changeRate":0.029247910863509745,"floatShares":3549571148,"shares":3549571148,"eps":0.704885,"marketStatus":"Trading","change":0.21,"latestTime":"03-10 11:25:26","open":7.18,"high":7.42,"low":7.18,"amount":17580432,"amplitude":0.033426,"askPrice":7.39,"askSize":3000,"bidPrice":7.38,"bidSize":2500,"shortable":3,"etf":0,"ttmEps":0.594325,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1773115200000},"marketStatusCode":2,"adr":0,"listingDate":819302400000,"exchange":"SEHK","adjPreClose":7.18,"dividendRate":0.035183,"openAndCloseTimeList":[[1773106200000,1773115200000],[1773118800000,1773129600000]],"volumeRatio":0.65571,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00512","defaultTab":"news","newsList":[{"id":"1186322011","title":"Grand Pharmaceutical Group (00512) Announces Monthly Return for February 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1186322011","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186322011?lang=en_us&edition=fundamental","pubTime":"2026-03-02 17:35","pubTimestamp":1772444111,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group Limited (stock code: 00512) submitted its monthly return for the period ending 28 February 2026. According to the announcement, the total authorized share capital remained...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512"],"gpt_icon":0},{"id":"2614896351","title":"Assessing Grand Pharmaceutical Group (SEHK:512) Valuation After Recent Earnings And Share Price Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=2614896351","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614896351?lang=en_us&edition=fundamental","pubTime":"2026-02-28 08:33","pubTimestamp":1772238787,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group (SEHK:512) has drawn investor attention after posting annual revenue of HK$11,704.979 million and net income of HK$2,079.449 million, putting fresh focus on how its diversified healthcare business is currently valued.\nSee our latest analysis for Grand Pharmaceutical Group.\nAt a share price of HK$7.83, Grand Pharmaceutical Group has seen short term share price pressure, with a 90 day share price return decline of 4.74%. However, its 1 year total shareholder return of...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-512/grand-pharmaceutical-group-shares/news/assessing-grand-pharmaceutical-group-sehk512-valuation-after","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-512/grand-pharmaceutical-group-shares/news/assessing-grand-pharmaceutical-group-sehk512-valuation-after","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","BK1191","00512"],"gpt_icon":0},{"id":"2608582983","title":"Grand Pharmaceutical Group Updates Acquisition of Hebei Yuanda Jiufu and Baoding Jiahe","url":"https://stock-news.laohu8.com/highlight/detail?id=2608582983","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608582983?lang=en_us&edition=fundamental","pubTime":"2026-02-03 17:06","pubTimestamp":1770109610,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group Ltd. has provided an update regarding its acquisition of the entire equity interests in Hebei Yuanda Jiufu Biotechnology Co., Ltd. and Baoding Jiahe Fine Chemical Co., Ltd. The transaction consideration is set at RMB316 million, determined through arm's length negotiations and based on factors such as the financial performance and business prospects of the target companies. Recent financial figures show the target companies reported combined revenues of RMB238.6 million in 2025 and RMB220.2 million in 2024, with net profits after tax of RMB35.8 million and RMB15.0 million for those respective years. The company also clarified that 17 comparable public companies were reviewed in determining the transaction terms.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be inte","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDLSYrGv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2604800154","title":"BUZZ-Australia's Telix Pharmaceuticals rises on China acceptance of new drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2604800154","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604800154?lang=en_us&edition=fundamental","pubTime":"2026-01-20 08:39","pubTimestamp":1768869566,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Telix Pharmaceuticals riseson China acceptance of new drug application ** Shares of Australia's Telix Pharmaceuticals TLX.AX rise as much as 6.3% to A$11.99, posting their biggest intraday pct gain in nearly two months** Stock touches its highest level since December-end** Biopharma co says the Chinese National Medical Products Administration  has accepted New Drug Application  for its prostate cancer diagnosis agent, Illuccix** Says NDA submitted in association with partner Grand Pharmaceutical Group 0512.HK in Greater China region ** Illuccix used as a scanning agent to detect prostate cancer in body** TLX among top gainers on the broader Australian benchmark index .AXJO, which is down 0.5%** TLX up 4.6% YTD after a 54.5% drop in 2025  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nL6N3YL011:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","00512","BK7067","BK4157","TNLX","TLX.AU"],"gpt_icon":0},{"id":"2604187093","title":"Grand Pharmaceutical Says Imaging Agent Accepted For Chinese Regulatory Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2604187093","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604187093?lang=en_us&edition=fundamental","pubTime":"2026-01-19 18:38","pubTimestamp":1768819087,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group (HKG:0512) said Chinese regulators accepted its imaging agent TLX591-CDx for review, according to a Hong Kong bourse filing Monday.TLX591-CDx previously met the main goal of a phase 3 study in China to diagnose prostate cancer.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"1173982504","title":"Grand Pharmaceutical's (00512) Innovative Radiopharmaceutical TLX591-CDx NDA Accepted by China's NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1173982504","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173982504?lang=en_us&edition=fundamental","pubTime":"2026-01-19 18:05","pubTimestamp":1768817143,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical (00512) announced that the New Drug Application (NDA) for its innovative investigational radiopharmaceutical conjugate (RDC) TLX591-CDx (Illuccix®, gallium Ga 68 PSMA-11),...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2604182999","title":"Grand Pharmaceutical - Nda of Rdc Tlx591-Cdx Is Accepted by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2604182999","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604182999?lang=en_us&edition=fundamental","pubTime":"2026-01-19 17:54","pubTimestamp":1768816456,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260119:nFWN3YK05X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2604182183","title":"Grand Pharmaceutical Group NDA for TLX591-CDx Accepted by NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2604182183","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604182183?lang=en_us&edition=fundamental","pubTime":"2026-01-19 17:54","pubTimestamp":1768816454,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group Ltd. announced that the New Drug Application  for its global innovative radiodiagnostic compound TLX591-CDx has been accepted by the National Medical Products Administration  of China. This acceptance marks a significant milestone in the Group's global research and development and registration process for nuclear medicine anti-tumor diagnosis and treatment. The company highlighted that while the product has reached its primary clinical endpoint, it is still under research and development, and commercialization approval remains subject to further regulatory processes and uncertainties.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grand Pharmaceutical Group Ltd. published the original content used to generate","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260119:nNDL3npqv4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2601584549","title":"The Bull Case For Grand Pharmaceutical Group (SEHK:512) Could Change Following Neffy Nasal Adrenaline Approval In China","url":"https://stock-news.laohu8.com/highlight/detail?id=2601584549","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601584549?lang=en_us&edition=fundamental","pubTime":"2026-01-07 01:18","pubTimestamp":1767719889,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group has announced that Neffy®, the world’s first adrenaline nasal spray, has obtained drug registration approval from China’s National Medical Products Administration for emergency treatment of type I allergic reactions in adults and children over 30kg, with exclusive commercialization rights in Mainland China and planned localized production within 24 months.\nThis marks the first non-injectable adrenaline treatment approved in China, potentially broadening real-world...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-512/grand-pharmaceutical-group-shares/news/the-bull-case-for-grand-pharmaceutical-group-sehk512-could-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-512/grand-pharmaceutical-group-shares/news/the-bull-case-for-grand-pharmaceutical-group-sehk512-could-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1191","00512"],"gpt_icon":0},{"id":"1184782069","title":"Four Consecutive Innovative Product Launches Signal Harvest Season for Grand Pharma's (00512) Product Ecosystem, Global Layout Opens New Chapter","url":"https://stock-news.laohu8.com/highlight/detail?id=1184782069","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184782069?lang=en_us&edition=fundamental","pubTime":"2026-01-05 09:52","pubTimestamp":1767577922,"startTime":"0","endTime":"0","summary":"By the end of 2025, Grand Pharma (00512) successively announced new progress on multiple innovative products, covering cutting-edge therapeutic areas such as radiopharmaceuticals, traditional Chinese...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"gpt_icon":0},{"id":"1127218046","title":"Expanding Territory! Grand Pharma (00512) Strengthens Core Competitive Edge in Amino Acids with Strategic Acquisition, Reinforcing Industry Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=1127218046","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127218046?lang=en_us&edition=fundamental","pubTime":"2025-12-31 16:59","pubTimestamp":1767171554,"startTime":"0","endTime":"0","summary":"Throughout December, Grand Pharma (00512) has been frequently announcing significant positive developments. As the year 2025 draws to a close, the company's biotechnology sector has once again...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","00512"],"gpt_icon":0},{"id":"2595722985","title":"Grand Pharmaceutical - Deal for Aggregate Consideration of RMB316 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2595722985","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595722985?lang=en_us&edition=fundamental","pubTime":"2025-12-31 16:43","pubTimestamp":1767170628,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nFWN3Y00J2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2595722983","title":"Grand Pharmaceutical - Hubei Yuanda to Buy Hebei Yuanda Jiufu Biotechnology and Baoding Jiahe Fine Chemical","url":"https://stock-news.laohu8.com/highlight/detail?id=2595722983","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595722983?lang=en_us&edition=fundamental","pubTime":"2025-12-31 16:43","pubTimestamp":1767170628,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nFWN3Y00J2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2595472298","title":"Grand Pharmaceutical Group Acquires Hebei Yuanda Jiufu and Baoding Jiahe Fine Chemical","url":"https://stock-news.laohu8.com/highlight/detail?id=2595472298","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595472298?lang=en_us&edition=fundamental","pubTime":"2025-12-31 16:42","pubTimestamp":1767170579,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group Limited has disclosed that its subsidiary, Grand Pharm  Company Limited , will acquire the entire equity interests in certain target companies from China Grand Enterprises Incorporation and Wuhan Jiuxiang Biotechnology Partnership. The move is expected to enhance the Group’s integrated industrial chain layout in the biotechnology sector, strengthen core competitiveness, and support the company’s diversification strategy in biotechnology. The terms of the transaction were agreed following arm’s length negotiations, and no director was required to abstain from the board resolution due to material interest.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grand Pharmaceutical Group Ltd. published the original cont","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nNDL9HYSy7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"gpt_icon":0},{"id":"1126290831","title":"GRAND PHARMA (00512) Achieves Milestone Breakthroughs Across Multiple Segments: Deepening \"Diagnosis-Treatment Integration\" in Nuclear Medicine, Fostering Multiple Growth Engines","url":"https://stock-news.laohu8.com/highlight/detail?id=1126290831","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126290831?lang=en_us&edition=fundamental","pubTime":"2025-12-30 09:08","pubTimestamp":1767056916,"startTime":"0","endTime":"0","summary":"The global field of nuclear medicine for oncology diagnosis and treatment is advancing at an unprecedented pace towards an era of \"diagnosis-treatment integration.\" As one of only four pharmaceutical...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"gpt_icon":0},{"id":"1179901517","title":"Zhiti Express HK Stock Morning Brief | Precious Metals Futures Plunge Collectively; National Energy Administration Promotes Planning and Construction of High-Power Charging Facilities","url":"https://stock-news.laohu8.com/highlight/detail?id=1179901517","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179901517?lang=en_us&edition=fundamental","pubTime":"2025-12-30 08:09","pubTimestamp":1767053340,"startTime":"0","endTime":"0","summary":"Today's Headlines The Ministry of Finance and the State Taxation Administration announced that tobacco enterprises' tobacco advertising and business promotion expenses are uniformly disallowed as...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348825331.USD","01880","LU0348735423.USD","LU0417516738.SGD","LU1720050803.USD","LU1794554557.SGD","LU0417516902.SGD","BK1224","159945","00512","BK1191"],"gpt_icon":0},{"id":"2595781816","title":"BRIEF-Grand Pharmaceutical Says Neffy Obtains Drug Registration Certificate From China's NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2595781816","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595781816?lang=en_us&edition=fundamental","pubTime":"2025-12-29 18:22","pubTimestamp":1767003763,"startTime":"0","endTime":"0","summary":"BRIEF-Grand Pharmaceutical Says Neffy Obtains Drug Registration Certificate From China's NMPADec 29 (Reuters) - Grand Pharmaceutical Group Ltd 0512.HK:NEFFY® OBTAINS DRUG REGISTRATION CERTIFICATE FROM CHINA'S NMPAFurther company coverage: 0512.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nFWN3XX012:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"gpt_icon":0},{"id":"1184346781","title":"GRAND PHARMA (00512) Secures Drug Registration Certificate for World's First Adrenaline Nasal Spray Treating Severe Allergic Reactions","url":"https://stock-news.laohu8.com/highlight/detail?id=1184346781","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184346781?lang=en_us&edition=fundamental","pubTime":"2025-12-29 17:11","pubTimestamp":1766999488,"startTime":"0","endTime":"0","summary":"GRAND PHARMA (00512) announced that through its collaboration with Youer Pharma, the group has recently secured the drug registration certificate from China's National Medical Products Administration...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2595578372","title":"Grand Pharmaceutical Group Wins China Approval for World's First Adrenaline Nasal Spray","url":"https://stock-news.laohu8.com/highlight/detail?id=2595578372","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595578372?lang=en_us&edition=fundamental","pubTime":"2025-12-29 17:00","pubTimestamp":1766998855,"startTime":"0","endTime":"0","summary":"Grand Pharmaceutical Group Limited announced that Neffy, the world's first adrenaline nasal spray for the emergency treatment of severe allergic reactions, has obtained a drug registration certificate from the National Medical Products Administration  of China. Developed in collaboration with Pediatrix Therapeutics, the product is approved for use in adults and children weighing 30kg or more. Grand Pharmaceutical Group holds exclusive commercialization rights for Mainland China and non-exclusive rights for Hong Kong.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grand Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchang","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nNDL2MjwSv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00512","BK1191"],"gpt_icon":0},{"id":"2595096783","title":"Grand Pharmaceutical Group Ltd - Neffy® Obtains Drug Registration Certificate From China's Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2595096783","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595096783?lang=en_us&edition=fundamental","pubTime":"2025-12-29 17:00","pubTimestamp":1766998850,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nFWN3XX012:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["00512","BK1191"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinagrandpharm.com","stockEarnings":[{"period":"1week","weight":-0.049},{"period":"1month","weight":-0.09},{"period":"3month","weight":-0.1201},{"period":"6month","weight":-0.2263},{"period":"1year","weight":0.417},{"period":"ytd","weight":-0.0854}],"compareEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":-0.0434},{"period":"3month","weight":-0.001},{"period":"6month","weight":-0.0302},{"period":"1year","weight":0.0486},{"period":"ytd","weight":-0.0087}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"China Grand Pharmaceutical and Healthcare Holdings Ltd is a Hong Kong-based investment holding company principally engaged in the manufacturing and sales of pharmaceutical preparations and medical devices. The Company is principally engaged in manufacturing and sales of pharmaceutical preparations and medical devices, bio-technology products, nutrition products, specialised pharmaceutical raw materials and other products. The main products of the Company cover the anti-tumor, cardiovascular emergency pharmaceutical products and advanced cerebro-cardiovascular intervention advanced medical devices, anti-virus and anti-infection, respiratory and ear-nose-throat (ENT), bio-health products and specialized pharmaceutical ingredients.","yearOnYearQuotes":[{"month":1,"riseRate":0.451613,"avgChangeRate":0.084101},{"month":2,"riseRate":0.709677,"avgChangeRate":0.105021},{"month":3,"riseRate":0.387097,"avgChangeRate":0.015784},{"month":4,"riseRate":0.633333,"avgChangeRate":0.018767},{"month":5,"riseRate":0.466667,"avgChangeRate":0.084333},{"month":6,"riseRate":0.366667,"avgChangeRate":-0.048262},{"month":7,"riseRate":0.366667,"avgChangeRate":-0.015905},{"month":8,"riseRate":0.4,"avgChangeRate":0.007133},{"month":9,"riseRate":0.466667,"avgChangeRate":-0.039275},{"month":10,"riseRate":0.5,"avgChangeRate":-0.014834},{"month":11,"riseRate":0.5,"avgChangeRate":0.085694},{"month":12,"riseRate":0.5,"avgChangeRate":-0.007596}],"exchange":"SEHK","name":"GRAND PHARMA","nameEN":"GRAND PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GRAND PHARMA(00512),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GRAND PHARMA(00512) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GRAND PHARMA,00512,GRAND PHARMA股票,GRAND PHARMA股票老虎,GRAND PHARMA股票老虎国际,GRAND PHARMA行情,GRAND PHARMA股票行情,GRAND PHARMA股价,GRAND PHARMA股市,GRAND PHARMA股票价格,GRAND PHARMA股票交易,GRAND PHARMA股票购买,GRAND PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GRAND PHARMA(00512),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GRAND PHARMA(00512) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}